Ikove is a venture development company pursuing early stage investments with emphasis on technology commercialization.
Ikove has launched 8 disruptive companies out of its Startup Nursery process, generating $50+ million in equity and convertible cap valuations, including:
– Nikola Labs: Wireless power for the IoT revolution
– Cognovi Labs: Deep learning and AI to better understand behavior and emotions
– eLum Technologies: Medical device company focusing on innovative neurovascular applications
_______
Ikove is aligned with multiple U.S. research institutions, and works in partnership with some of our nation’s brightest minds to bring innovative technology to life.
There is over $60 billion invested into Research and Development in the United States. However, less than 1% of that is invested in commercialization, leaving some of the most powerful technologies stuck on a shelf.
Through its proprietary “Startup Nursery,” Ikove identifies and validates developing high-impact technologies, providing capital and commercialization resources to bridge the development gap between R&D funding and VC-funded rounds.
In addition to providing capital, Ikove forms high caliber “Launch Teams” to navigate the complex and difficult path to market faced by technology startups, with the underlying goal of solidifying robust revenue streams and customer bases.
_______
Ikove is headquartered in Columbus, Ohio and has partners, advisors and directors in New York, Silicon Valley, Chicago, Monaco, London, Hong Kong, Shanghai and Rio de Janeiro.
The Startup Nursery Innovation and Technology Fund (SUN Fund) is an investment vehicle created to allow strategic investors exclusive access to participate into Ikove’s proprietary technology investment and commercialization program.
Gain exclusive access to extraordinary companies including featured below:
Nikola Labs, Cognovi Labs, & eLum Technologies!
Nikola has created an advanced radio frequency (RF) to direct current (DC) circuit that reduces the cost and complexity of incorporating wireless power into a wide variety of products.
Nikola is working closely with Texas Instruments and Skyworks on the development and manufacturing of both current and future generations of low cost integrated RF to DC chips.
Cognovi Labs uses deep learning and AI to better understand behavior and emotions.
The technology has been developed and validated over the past eight years with demonstrable success in predicting the 2016 British EU Referendum (Brexit) and 2016 Presidential Election.
eLum Technologies LLC is a medical device company developing a full portfolio of neurovascular devices, enabling it to capture a significant percentage of the $2B neurovascular market.
CWD is poised to upset the existing speed reducer landscape, as it offers a longer life span and lower cost of materials and fabrication than current solutions.
SolitonReach is poised to upend the VR/AR market, offering unique mobility and drift-free operation at a low cost. SolitonReach is being validated for diagnostic/therapeutic application via clinical trials at two major hospitals.
John is a Founder and Managing Partner of Ikove Venture Partners and Founder & CEO of Ikove Advisory Partners, powering commercialization efforts at leading research institutions. John is a Founder of Proton Enterprises and is an InBIA certified Incubator Manager.
John previously Co-Founded Naples Dock Staining, has worked in finance with Federated Investors, and manages a personal investment portfolio. He also worked on social business development in Haiti as a Managing Partner of Sitwayen Development Group and Board Member of LEVE Foundation.
John graduated cum laude from Xavier University with a Bachelor’s Degree in Business Management and minor in Entrepreneurial Studies. In 2016, John was awarded the Xavier University Magis Award, which recognizes an alumnus who, within 15 years of graduation, has achieved a high degree of excellence and embodies Jesuit morals and ethical values.
John is an FAA licensed pilot and enjoys skiing, boating, and spearfishing.
Flavio is a Founder & Managing Partner of Ikove Venture Partners, bringing over 20 years of financial and business development experience.
Previously, he was an Executive Director at Liongate Capital Management, a $7 billion alternative investment manager based in London / New York. Prior to Liongate, Flavio was a Managing Director and CIO at Atlas One Capital Management, where he was responsible for global hedge fund portfolios. Additionally, Flavio was a Founder and CIO of Swiss Capital Asset Management in Lugano, managing over $1.5 billion in hedge fund investments for institutional clients. Flavio was a VP at Goldman Sachs & Co. and a Director at Credit Suisse First Boston.
Flavio received his MBA from Harvard Business School with honors, and his undergraduate degree in International Finance / Marketing from the University of Miami, cum laude. Flavio is an Advisor to the Harvard Innovation Lab (I-Lab) and is an active member and FinTech Sector Lead of the HBS Angels of NYC.
Rodolfo Bellesi is a Managing Partner and Co-Founder of Ikove Venture Partners. His vision for commercializing technologies out of the Midwest brought forth the Ikove Startup Nursery.
Prior to Ikove, Rodolfo was Senior VP of Technology at MB Capital, a Private Equity and Real Estate Group focused on proprietary deals in Northern Brazil. He was also Founder and President of BR Trading Consultoria LTDA, and acted as General Country Manager for the mining conglomerate Energold Brasil. Additionally, he worked at Teradyne in Boston, MA as an Application Engineer and Project Manager.
Rodolfo pursued his MBA in Entrepreneurship from Babson College, a M.S. in Electrical Engineering from the Ohio State University, and a B.S. in Electrical Engineering from the Federal University of Para.